Scopolamine Patch, Extended Release
Product Images NDC 70710-1846

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 70710-1846). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 01)

Chemical structure of scopolamine showing its molecular configuration with identifiable atoms and bonds, including a bicyclic ring system and an aromatic phenyl group.*

FDA Label Image

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 02)

An instructional diagram showing the layered structure of a Scopolamine transdermal patch. The layers from top to bottom are labeled as Backing Membrane, Drug Layer, Rate Controlling Membrane, Contact Layer, and Release Liner.*

FDA Label Image

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 03)

An instructional illustration showing a transdermal scopolamine patch with labeled parts including a clear disposable release liner, an adhesive surface, and a tan backing membrane imprinted with "Scopolamine 1 mg/3 days." The diagram highlights the patch components for user reference.*

FDA Label Image

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 04)

An instructional diagram illustrating how to open the tear package for Scopolamine extended-release transdermal patches. It shows a rectangular package with labeled notch and slit areas, indicating where to tear the packaging for easy opening.*

FDA Label Image

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 05)

An instructional illustration labeled as Figure 3, depicting hands holding a triangular-shaped object, likely demonstrating how to handle or open a transdermal patch. The image focuses on finger placement on the patch edges.*

FDA Label Image

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 06)

An instructional diagram showing the application of a Scopolamine 1 mg/3d extended-release transdermal patch. The image highlights the patch's tan-colored transdermal system, adhesive surface, and clear disposable release liner, demonstrating proper handling by a hand.*

FDA Label Image

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 07)

An illustration showing a side profile of a human head with the approximate placement area of a scopolamine transdermal patch behind the ear. The patch is indicated as part of the transdermal system and is color-imprinted. This diagram corresponds to the extended-release scopolamine patch for transdermal use.*

FDA Label Image

Carton Labels (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 08)

Scopolamine 1 mg/3 days transdermal system packaging label by Zydus Pharmaceuticals USA Inc. The label describes a patch extended release dosage form designed for delivery of approximately 1 mg over three days. The multipack contains 4 transdermal systems. The label includes directions, storage instructions, and manufacturer information, with the product NDC 70710-1846-4 visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.